The latest price target for Acuren (AMEX:TIC) was reported by UBS on March 21, 2025. The analyst firm set a price target for $13.00 expecting TIC to rise to within 12 months (a possible 33.61% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Acuren (AMEX:TIC) was provided by UBS, and Acuren initiated their neutral rating.

There is no last upgrade for Acuren

There is no last downgrade for Acuren.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acuren, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acuren was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.

While ratings are subjective and will change, the latest Acuren (TIC) rating was a initiated with a price target of $0.00 to $13.00. The current price Acuren (TIC) is trading at is $9.73, which is within the analyst’s predicted range.